Form 4 for BHVN Biohaven Ltd.
Accepted 2026-01-07 00:00:00 ET · period of report 2026-01-05 · accession 0001704186-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-07 | 2026-01-05 | BHVN | Gentile Kimberly | SVP, Clinical Ops | F - Tax | $9.93 | -1,956 | 99.6K | -2% | -$19.4K |
| D | 2026-01-07 | 2026-01-05 | BHVN | Gentile Kimberly | SVP, Clinical Ops | M - OptEx | $0.00 | +3,750 | 101.5K | +4% | $0 |
| D | 2026-01-07 | 2026-01-05 | BHVN | Gentile Kimberly | SVP, Clinical Ops | M - OptEx | $0.00 | -3,750 | 7,500 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-01-05 | F | D | 1,956 | $9.93 | 99,557 | D | — | — | (F1) No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units. |
| 2 | Common | Common Shares | 2026-01-05 | M | A | 3,750 | $0.00 | 101,513 | D | — | — | |
| 3 | Derivative | Restricted Share Unit Award | 2026-01-05 | M | D | 3,750 | $0.00 | 7,500 | D | — · — to — | 3,750 Common Shares | (F2) Each restricted share unit represents the contingent right to receive one common share of the Issuer. (F3) The reporting person was granted 15,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date. (F4) Not applicable. |